Citigroup’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$777K Sell
66,691
-24,106
-27% -$281K ﹤0.01% 2654
2025
Q1
$675K Sell
90,797
-8,815
-9% -$65.5K ﹤0.01% 2791
2024
Q4
$597K Sell
99,612
-8,929
-8% -$53.5K ﹤0.01% 2909
2024
Q3
$556K Buy
108,541
+47,535
+78% +$243K ﹤0.01% 2925
2024
Q2
$221K Sell
61,006
-79,916
-57% -$289K ﹤0.01% 3117
2024
Q1
$452K Buy
140,922
+114,571
+435% +$368K ﹤0.01% 2923
2023
Q4
$129K Buy
26,351
+19,504
+285% +$95.6K ﹤0.01% 3363
2023
Q3
$37.3K Sell
6,847
-37,566
-85% -$205K ﹤0.01% 3535
2023
Q2
$298K Buy
44,413
+34,335
+341% +$230K ﹤0.01% 3030
2023
Q1
$89K Sell
10,078
-2,650
-21% -$23.4K ﹤0.01% 3439
2022
Q4
$97.2K Sell
12,728
-1,429
-10% -$10.9K ﹤0.01% 3351
2022
Q3
$101K Sell
14,157
-11,447
-45% -$81.7K ﹤0.01% 3385
2022
Q2
$207K Sell
25,604
-2,771
-10% -$22.4K ﹤0.01% 3178
2022
Q1
$394K Buy
28,375
+4,047
+17% +$56.2K ﹤0.01% 2996
2021
Q4
$683K Sell
24,328
-5,848
-19% -$164K ﹤0.01% 2864
2021
Q3
$1.03M Sell
30,176
-5,270
-15% -$179K ﹤0.01% 2377
2021
Q2
$1.45M Buy
35,446
+9,655
+37% +$394K ﹤0.01% 2349
2021
Q1
$1.04M Sell
25,791
-4,086
-14% -$164K ﹤0.01% 2355
2020
Q4
$1.77M Sell
29,877
-1,461
-5% -$86.4K ﹤0.01% 1786
2020
Q3
$1.52M Sell
31,338
-2,254
-7% -$110K ﹤0.01% 1668
2020
Q2
$1.63M Sell
33,592
-106,842
-76% -$5.17M ﹤0.01% 1772
2020
Q1
$3.9M Buy
140,434
+13
+0% +$361 ﹤0.01% 1052
2019
Q4
$4.2M Buy
140,421
+92,486
+193% +$2.77M ﹤0.01% 1198
2019
Q3
$1.48M Buy
+47,935
New +$1.48M ﹤0.01% 1831